High Uric Acid (8.4 mg/dL): Risks and Management

A serum uric acid level of 8.4 mg/dL is elevated (normal: men <7.0, women <6.0 mg/dL). Hyperuricemia promotes monosodium urate crystal deposition, causing gout flares and tophi. It is also independently associated with:

  • Chronic kidney disease (urate nephropathy, nephrolithiasis).
  • Cardiovascular disease (hypertension, coronary artery disease, heart failure).
  • Metabolic syndrome (insulin resistance, obesity, dyslipidemia).

Management

  • Lifestyle: Low-purine diet (limit red meat, organ meats, shellfish, alcohol—especially beer), hydration (≥2 L water/day), weight loss if overweight.
  • Medications: Urate-lowering therapy (allopurinol first-line, febuxostat if intolerant) indicated for frequent flares, tophi, CKD, or urolithiasis. Target urate <6 mg/dL (<5 mg/dL if tophi).
  • Prophylaxis: Colchicine 0.6 mg daily/biweekly during ULT initiation to prevent flares.
  • Monitor: Serum urate, renal function, CBC periodically.

Asymptomatic hyperuricemia alone doesn't always require pharmacotherapy; shared decision-making with a rheumatologist or PCP is advised.

Urinary Disorders - Related Articles